Docetaxel 80mg

Docetaxel 80mg

Product Overview

Generic NameDocetaxel 80mg
Brand Name(s)Taxotere
CategoryAntineoplastic / Cancer
FormIV concentrate/injection vials
Strength80 mg/4mL
Therapeutic ClassAntineoplastic taxane (mitotic inhibitor)
ATC CodeL01CD02

Manufacturing & Regulatory

GMP ComplianceWHO-GMP certified
DMF/CEPType II/III
COFEPRIS010.000.5437.01
Free Sale CertificateYes, available as COPP/CPP

Logistics & Export

MOQ10 units
Shelf Life36 months
Storage2–8 °C
IncotermsEx-Works Mexico
Lead Time7 to 10 Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Yes
CTD Summary (PDF)Not publicly available as parallel traded molecule

Special Notes

Docetaxel is an injectable antineoplastic chemotherapy agent used in oncology for the treatment of multiple solid tumors, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers. It is generally administered by intravenous infusion under specialist oncology supervision and may be used alone or in combination with other chemotherapy or supportive medicines depending on the approved treatment protocol